Substrates for peptidase C25.001: gingipain RgpA
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| apolipoprotein B-100 | P04114 | 28-4563 | peptide-Arg158+Gly-peptide | N | Asn | Ile | Lys | Arg | Gly | Ile | Ile | Ser | Bengtsson et al., 2008 | 20574 | ||
| apolipoprotein B-100 | P04114 | 28-4563 | peptide-Arg207+Asp-peptide | N | Ser | Thr | Glu | Arg | Asp | Leu | Gly | Gln | Bengtsson et al., 2008 | 20575 | ||
| Bz-Arg-NHPhNO2 (BAPNA) | Bz-Arg+NHPhNO2 | S | - | - | Bz | Arg | NAN | - | - | - | Imamura et al., 2004 | |||||
| coagulation factor IX | P00740 | 47-461 | peptide-Arg191+Ala-peptide | N | Lys | Leu | Thr | Arg | Ala | Glu | Thr | Val | Imamura et al., 2001 | 20589 | ||
| coagulation factor IX | P00740 | 47-461 | peptide-Arg226+Val-peptide | N | Asp | Phe | Thr | Arg | Val | Val | Gly | Gly | Imamura et al., 2001 | 20590 | ||
| coagulation factor X light chain | P00742 | 41-488 | peptide-Arg469+Gly-peptide | N | CS | Met | Lys | Thr | Arg | Gly | Leu | Pro | Lys | Imamura et al., 1997 | 20579 | |
| coagulation factor X light chain | P00742 | 41-488 | peptide-Arg227+Gly-peptide | N | CS | Gln | Pro | Glu | Arg | Gly | Asp | Asn | Asn | Imamura et al., 1997 | 20580 | |
| coagulation factor X light chain | P00742 | 41-488 | peptide-Arg234+Ile-peptide | N | CS | Asn | Leu | Thr | Arg | Ile | Val | Gly | Gly | Imamura et al., 1997 | 20581 | |
| consensus arginyl bond | peptide-Arg+peptide | N | - | - | NPe | Arg | CPe | - | - | - | Imamura et al., 2004 | |||||
| cystatin C | P01034 | 27-146 | peptide-Arg34+Leu-peptide | N | Lys | Pro | Pro | Arg | Leu | Val | Gly | Gly | Abrahamson et al., 1998 | 20563 | ||
| elafin | P19957 | 61-117 | peptide-Arg82+Cys-peptide | N | MS | Ile | Leu | Ile | Arg | Cys | Ala | Met | Leu | Kantyka et al., 2009 | ||
| fimbrilin type 1 long precursor isoform | P0C940 | 1-347 | peptide-Arg46+Ala-peptide | P | Asn | Ser | Asn | Arg | Ala | Phe | Gly | Val | Imamura et al., 2004 | 16282 | ||
| gingipain R precursor | P28784 | 25-991 | peptide-Arg203+Tyr-peptide | P | Glu | Pro | Gly | Arg | Tyr | Thr | Pro | Val | Imamura et al., 2004 | 16287 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg+Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Cya | Gly | Glu | Arg | Gly | Phe | Phe | Tyr | Imamura et al., 2004 | |||
| interleukin-6 | P05231 | 30-212 | peptide-Arg44+Gln-peptide | N | Ala | Pro | His | Arg | Gln | Pro | Leu | Thr | Banbula et al., 1999 | 18862 | ||
| interleukin-6 | P05231 | 30-212 | peptide-Arg207+Ala-peptide | N | Ser | Ser | Leu | Arg | Ala | Leu | Arg | Gln | Banbula et al., 1999 | 18863 | ||
| interleukin-8 | P10145 | 23-99 | peptide-Arg27+Ser-peptide | N | Val | Leu | Pro | Arg | Ser | Ala | Lys | Glu | Dias et al., 2007 | 20570 | ||
| interleukin-8 | P10145 | 23-99 | peptide-Arg33+Cys-peptide | N | Lys | Glu | Leu | Arg | Cys | Gln | Cys | Ile | Dias et al., 2007 | 20573 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Arg371+Ser-peptide | N | Ser | Pro | Phe | Arg | Ser | Ser | Arg | Ile | Imamura et al., 2004 | |||
| kininogen-1 | P01042 | 19-644 | peptide-Lys362+Arg-peptide | N | Ser | Leu | Met | Lys | Arg | Pro | Pro | Gly | Imamura et al., 2004 | |||
| mellitin | P01501 | 44-69 | Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg+Lys-Arg-Gln-Gln-NH2 | N | Trp | Ile | Lys | Arg | Lys | Arg | Gln | Gln | Imamura et al., 2004 | |||
| mellitin | P01501 | 44-69 | Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg+Gln-Gln-NH2 | N | Lys | Arg | Lys | Arg | Gln | Gln | NH2 | - | Imamura et al., 2004 | |||
| N-acetyl-S-farnesyl-Cys-Val-Ile-Met | N-acetyl-S-farnesyl-Cys+Val-Ile-Met | N | - | - | Ac | Cyf | Val | Ile | Met | - | Imamura et al., 2004 | |||||
| Pg-II fimbriae b precursor | Q8KHA3 | 1-561 | peptide-Arg49+Ala-peptide | P | Gly | Ser | Ala | Arg | Ala | Gly | Asp | Gly | Imamura et al., 2004 | 16286 | ||
| tumor necrosis factor | P01375 | 77-233 | peptide-Arg78+Ser-peptide | N | - | - | Val | Arg | Ser | Ser | Ser | Arg | Calkins et al., 1998 | 20521 | ||
| tumor necrosis factor | P01375 | 77-233 | peptide-Arg82+Thr-peptide | N | Ser | Ser | Ser | Arg | Thr | Pro | Ser | Asp | Calkins et al., 1998 | 20531 |
